nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—Abdominal pain—Azathioprine—systemic scleroderma	0.000714	0.000714	CcSEcCtD
Salbutamol—Body temperature increased—Azathioprine—systemic scleroderma	0.000714	0.000714	CcSEcCtD
Salbutamol—Skin disorder—Lisinopril—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Salbutamol—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00071	0.00071	CcSEcCtD
Salbutamol—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000709	0.000709	CcSEcCtD
Salbutamol—Diarrhoea—Captopril—systemic scleroderma	0.000708	0.000708	CcSEcCtD
Salbutamol—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000707	0.000707	CcSEcCtD
Salbutamol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000707	0.000707	CcSEcCtD
Salbutamol—Irritability—Methotrexate—systemic scleroderma	0.000707	0.000707	CcSEcCtD
Salbutamol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000706	0.000706	CcSEcCtD
Salbutamol—Feeling abnormal—Leflunomide—systemic scleroderma	0.000703	0.000703	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000703	0.000703	CcSEcCtD
Salbutamol—Fatigue—Mycophenolic acid—systemic scleroderma	0.000702	0.000702	CcSEcCtD
Salbutamol—Mood swings—Methotrexate—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Salbutamol—Nausea—Mometasone—systemic scleroderma	0.0007	0.0007	CcSEcCtD
Salbutamol—Anorexia—Lisinopril—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Salbutamol—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000698	0.000698	CcSEcCtD
Salbutamol—Ataxia—Methotrexate—systemic scleroderma	0.000696	0.000696	CcSEcCtD
Salbutamol—Pain—Mycophenolic acid—systemic scleroderma	0.000696	0.000696	CcSEcCtD
Salbutamol—Constipation—Mycophenolic acid—systemic scleroderma	0.000696	0.000696	CcSEcCtD
Salbutamol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000695	0.000695	CcSEcCtD
Salbutamol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000692	0.000692	CcSEcCtD
Salbutamol—Hyperglycaemia—Prednisone—systemic scleroderma	0.000691	0.000691	CcSEcCtD
Salbutamol—Cough—Mycophenolate mofetil—systemic scleroderma	0.000687	0.000687	CcSEcCtD
Salbutamol—Hypotension—Lisinopril—systemic scleroderma	0.000685	0.000685	CcSEcCtD
Salbutamol—Dizziness—Captopril—systemic scleroderma	0.000684	0.000684	CcSEcCtD
Salbutamol—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000679	0.000679	CcSEcCtD
Salbutamol—Urticaria—Leflunomide—systemic scleroderma	0.000678	0.000678	CcSEcCtD
Salbutamol—Abdominal pain—Leflunomide—systemic scleroderma	0.000674	0.000674	CcSEcCtD
Salbutamol—Body temperature increased—Leflunomide—systemic scleroderma	0.000674	0.000674	CcSEcCtD
Salbutamol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000671	0.000671	CcSEcCtD
Salbutamol—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00067	0.00067	CcSEcCtD
Salbutamol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00067	0.00067	CcSEcCtD
Salbutamol—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00067	0.00067	CcSEcCtD
Salbutamol—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000669	0.000669	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000668	0.000668	CcSEcCtD
Salbutamol—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000668	0.000668	CcSEcCtD
Salbutamol—Hypersensitivity—Azathioprine—systemic scleroderma	0.000666	0.000666	CcSEcCtD
Salbutamol—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000666	0.000666	CcSEcCtD
Salbutamol—Insomnia—Lisinopril—systemic scleroderma	0.000663	0.000663	CcSEcCtD
Salbutamol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000662	0.000662	CcSEcCtD
Salbutamol—Paraesthesia—Lisinopril—systemic scleroderma	0.000658	0.000658	CcSEcCtD
Salbutamol—Vomiting—Captopril—systemic scleroderma	0.000658	0.000658	CcSEcCtD
Salbutamol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000655	0.000655	CcSEcCtD
Salbutamol—Dyspnoea—Lisinopril—systemic scleroderma	0.000654	0.000654	CcSEcCtD
Salbutamol—Rash—Captopril—systemic scleroderma	0.000653	0.000653	CcSEcCtD
Salbutamol—Dermatitis—Captopril—systemic scleroderma	0.000652	0.000652	CcSEcCtD
Salbutamol—Somnolence—Lisinopril—systemic scleroderma	0.000652	0.000652	CcSEcCtD
Salbutamol—Headache—Captopril—systemic scleroderma	0.000648	0.000648	CcSEcCtD
Salbutamol—Dyspepsia—Lisinopril—systemic scleroderma	0.000645	0.000645	CcSEcCtD
Salbutamol—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000643	0.000643	CcSEcCtD
Salbutamol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000643	0.000643	CcSEcCtD
Salbutamol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Salbutamol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Salbutamol—Asthma—Methotrexate—systemic scleroderma	0.00064	0.00064	CcSEcCtD
Salbutamol—Infection—Mycophenolate mofetil—systemic scleroderma	0.000638	0.000638	CcSEcCtD
Salbutamol—Decreased appetite—Lisinopril—systemic scleroderma	0.000637	0.000637	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000633	0.000633	CcSEcCtD
Salbutamol—Fatigue—Lisinopril—systemic scleroderma	0.000632	0.000632	CcSEcCtD
Salbutamol—Shock—Mycophenolate mofetil—systemic scleroderma	0.000632	0.000632	CcSEcCtD
Salbutamol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00063	0.00063	CcSEcCtD
Salbutamol—Hypersensitivity—Leflunomide—systemic scleroderma	0.000629	0.000629	CcSEcCtD
Salbutamol—Pain—Lisinopril—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Salbutamol—Constipation—Lisinopril—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Salbutamol—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000627	0.000627	CcSEcCtD
Salbutamol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000624	0.000624	CcSEcCtD
Salbutamol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000621	0.000621	CcSEcCtD
Salbutamol—Diarrhoea—Azathioprine—systemic scleroderma	0.000618	0.000618	CcSEcCtD
Salbutamol—Haemoglobin—Prednisone—systemic scleroderma	0.000616	0.000616	CcSEcCtD
Salbutamol—Nausea—Captopril—systemic scleroderma	0.000615	0.000615	CcSEcCtD
Salbutamol—Haemorrhage—Prednisone—systemic scleroderma	0.000613	0.000613	CcSEcCtD
Salbutamol—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000612	0.000612	CcSEcCtD
Salbutamol—Asthenia—Leflunomide—systemic scleroderma	0.000612	0.000612	CcSEcCtD
Salbutamol—Feeling abnormal—Lisinopril—systemic scleroderma	0.000604	0.000604	CcSEcCtD
Salbutamol—Pruritus—Leflunomide—systemic scleroderma	0.000604	0.000604	CcSEcCtD
Salbutamol—Connective tissue disorder—Prednisone—systemic scleroderma	0.000602	0.000602	CcSEcCtD
Salbutamol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.0006	0.0006	CcSEcCtD
Salbutamol—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000599	0.000599	CcSEcCtD
Salbutamol—Dysuria—Methotrexate—systemic scleroderma	0.000598	0.000598	CcSEcCtD
Salbutamol—Dizziness—Azathioprine—systemic scleroderma	0.000597	0.000597	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000585	0.000585	CcSEcCtD
Salbutamol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000584	0.000584	CcSEcCtD
Salbutamol—Diarrhoea—Leflunomide—systemic scleroderma	0.000584	0.000584	CcSEcCtD
Salbutamol—Urticaria—Lisinopril—systemic scleroderma	0.000582	0.000582	CcSEcCtD
Salbutamol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000581	0.000581	CcSEcCtD
Salbutamol—Body temperature increased—Lisinopril—systemic scleroderma	0.000579	0.000579	CcSEcCtD
Salbutamol—Abdominal pain—Lisinopril—systemic scleroderma	0.000579	0.000579	CcSEcCtD
Salbutamol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000577	0.000577	CcSEcCtD
Salbutamol—Pruritus—Mycophenolic acid—systemic scleroderma	0.000576	0.000576	CcSEcCtD
Salbutamol—Vomiting—Azathioprine—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Salbutamol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000573	0.000573	CcSEcCtD
Salbutamol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000571	0.000571	CcSEcCtD
Salbutamol—Drowsiness—Methotrexate—systemic scleroderma	0.00057	0.00057	CcSEcCtD
Salbutamol—Rash—Azathioprine—systemic scleroderma	0.00057	0.00057	CcSEcCtD
Salbutamol—Dermatitis—Azathioprine—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Salbutamol—Flushing—Prednisone—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Salbutamol—Headache—Azathioprine—systemic scleroderma	0.000566	0.000566	CcSEcCtD
Salbutamol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000565	0.000565	CcSEcCtD
Salbutamol—Dizziness—Leflunomide—systemic scleroderma	0.000564	0.000564	CcSEcCtD
Salbutamol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000558	0.000558	CcSEcCtD
Salbutamol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000557	0.000557	CcSEcCtD
Salbutamol—Stomatitis—Methotrexate—systemic scleroderma	0.000556	0.000556	CcSEcCtD
Salbutamol—Angiopathy—Prednisone—systemic scleroderma	0.000556	0.000556	CcSEcCtD
Salbutamol—Conjunctivitis—Methotrexate—systemic scleroderma	0.000555	0.000555	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000555	0.000555	CcSEcCtD
Salbutamol—Immune system disorder—Prednisone—systemic scleroderma	0.000554	0.000554	CcSEcCtD
Salbutamol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000549	0.000549	CcSEcCtD
Salbutamol—Pain—Mycophenolate mofetil—systemic scleroderma	0.000549	0.000549	CcSEcCtD
Salbutamol—Arrhythmia—Prednisone—systemic scleroderma	0.000547	0.000547	CcSEcCtD
Salbutamol—Sweating—Methotrexate—systemic scleroderma	0.000547	0.000547	CcSEcCtD
Salbutamol—Haematuria—Methotrexate—systemic scleroderma	0.000544	0.000544	CcSEcCtD
Salbutamol—Vomiting—Leflunomide—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Salbutamol—Hypersensitivity—Lisinopril—systemic scleroderma	0.00054	0.00054	CcSEcCtD
Salbutamol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000538	0.000538	CcSEcCtD
Salbutamol—Epistaxis—Methotrexate—systemic scleroderma	0.000538	0.000538	CcSEcCtD
Salbutamol—Rash—Leflunomide—systemic scleroderma	0.000538	0.000538	CcSEcCtD
Salbutamol—Dermatitis—Leflunomide—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Salbutamol—Mental disorder—Prednisone—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Salbutamol—Nausea—Azathioprine—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Salbutamol—Headache—Leflunomide—systemic scleroderma	0.000534	0.000534	CcSEcCtD
Salbutamol—Malnutrition—Prednisone—systemic scleroderma	0.000533	0.000533	CcSEcCtD
Salbutamol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000529	0.000529	CcSEcCtD
Salbutamol—Asthenia—Lisinopril—systemic scleroderma	0.000526	0.000526	CcSEcCtD
Salbutamol—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000525	0.000525	CcSEcCtD
Salbutamol—Pruritus—Lisinopril—systemic scleroderma	0.000519	0.000519	CcSEcCtD
Salbutamol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000517	0.000517	CcSEcCtD
Salbutamol—Haemoglobin—Methotrexate—systemic scleroderma	0.000515	0.000515	CcSEcCtD
Salbutamol—Rash—Mycophenolic acid—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Salbutamol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Salbutamol—Haemorrhage—Methotrexate—systemic scleroderma	0.000512	0.000512	CcSEcCtD
Salbutamol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00051	0.00051	CcSEcCtD
Salbutamol—Headache—Mycophenolic acid—systemic scleroderma	0.00051	0.00051	CcSEcCtD
Salbutamol—Pharyngitis—Methotrexate—systemic scleroderma	0.000508	0.000508	CcSEcCtD
Salbutamol—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000508	0.000508	CcSEcCtD
Salbutamol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000508	0.000508	CcSEcCtD
Salbutamol—Nausea—Leflunomide—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Salbutamol—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000506	0.000506	CcSEcCtD
Salbutamol—Urethral disorder—Methotrexate—systemic scleroderma	0.000502	0.000502	CcSEcCtD
Salbutamol—Diarrhoea—Lisinopril—systemic scleroderma	0.000502	0.000502	CcSEcCtD
Salbutamol—Ill-defined disorder—Prednisone—systemic scleroderma	0.000495	0.000495	CcSEcCtD
Salbutamol—Agitation—Prednisone—systemic scleroderma	0.00049	0.00049	CcSEcCtD
Salbutamol—Angioedema—Prednisone—systemic scleroderma	0.000487	0.000487	CcSEcCtD
Salbutamol—Dizziness—Lisinopril—systemic scleroderma	0.000485	0.000485	CcSEcCtD
Salbutamol—Nausea—Mycophenolic acid—systemic scleroderma	0.000483	0.000483	CcSEcCtD
Salbutamol—Malaise—Prednisone—systemic scleroderma	0.000481	0.000481	CcSEcCtD
Salbutamol—Vertigo—Prednisone—systemic scleroderma	0.000479	0.000479	CcSEcCtD
Salbutamol—Syncope—Prednisone—systemic scleroderma	0.000478	0.000478	CcSEcCtD
Salbutamol—Tinnitus—Methotrexate—systemic scleroderma	0.000477	0.000477	CcSEcCtD
Salbutamol—Cardiac disorder—Methotrexate—systemic scleroderma	0.000475	0.000475	CcSEcCtD
Salbutamol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000473	0.000473	CcSEcCtD
Salbutamol—Loss of consciousness—Prednisone—systemic scleroderma	0.000469	0.000469	CcSEcCtD
Salbutamol—Vomiting—Lisinopril—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Salbutamol—Angiopathy—Methotrexate—systemic scleroderma	0.000465	0.000465	CcSEcCtD
Salbutamol—Immune system disorder—Methotrexate—systemic scleroderma	0.000463	0.000463	CcSEcCtD
Salbutamol—Rash—Lisinopril—systemic scleroderma	0.000462	0.000462	CcSEcCtD
Salbutamol—Dermatitis—Lisinopril—systemic scleroderma	0.000462	0.000462	CcSEcCtD
Salbutamol—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000462	0.000462	CcSEcCtD
Salbutamol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000461	0.000461	CcSEcCtD
Salbutamol—Hypertension—Prednisone—systemic scleroderma	0.000461	0.000461	CcSEcCtD
Salbutamol—Chills—Methotrexate—systemic scleroderma	0.00046	0.00046	CcSEcCtD
Salbutamol—Headache—Lisinopril—systemic scleroderma	0.000459	0.000459	CcSEcCtD
Salbutamol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Salbutamol—Myalgia—Prednisone—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Salbutamol—Arthralgia—Prednisone—systemic scleroderma	0.000454	0.000454	CcSEcCtD
Salbutamol—Anxiety—Prednisone—systemic scleroderma	0.000453	0.000453	CcSEcCtD
Salbutamol—Discomfort—Prednisone—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Salbutamol—Mental disorder—Methotrexate—systemic scleroderma	0.000449	0.000449	CcSEcCtD
Salbutamol—Malnutrition—Methotrexate—systemic scleroderma	0.000446	0.000446	CcSEcCtD
Salbutamol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000439	0.000439	CcSEcCtD
Salbutamol—Dysgeusia—Methotrexate—systemic scleroderma	0.000437	0.000437	CcSEcCtD
Salbutamol—Nausea—Lisinopril—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Salbutamol—Oedema—Prednisone—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Salbutamol—Anaphylactic shock—Prednisone—systemic scleroderma	0.000435	0.000435	CcSEcCtD
Salbutamol—Infection—Prednisone—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Salbutamol—Back pain—Methotrexate—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Salbutamol—Shock—Prednisone—systemic scleroderma	0.000428	0.000428	CcSEcCtD
Salbutamol—Nervous system disorder—Prednisone—systemic scleroderma	0.000427	0.000427	CcSEcCtD
Salbutamol—Tachycardia—Prednisone—systemic scleroderma	0.000425	0.000425	CcSEcCtD
Salbutamol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000425	0.000425	CcSEcCtD
Salbutamol—Skin disorder—Prednisone—systemic scleroderma	0.000423	0.000423	CcSEcCtD
Salbutamol—Hyperhidrosis—Prednisone—systemic scleroderma	0.000421	0.000421	CcSEcCtD
Salbutamol—Anorexia—Prednisone—systemic scleroderma	0.000415	0.000415	CcSEcCtD
Salbutamol—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000414	0.000414	CcSEcCtD
Salbutamol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000408	0.000408	CcSEcCtD
Salbutamol—Rash—Mycophenolate mofetil—systemic scleroderma	0.000405	0.000405	CcSEcCtD
Salbutamol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000405	0.000405	CcSEcCtD
Salbutamol—Headache—Mycophenolate mofetil—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Salbutamol—Malaise—Methotrexate—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Salbutamol—Vertigo—Methotrexate—systemic scleroderma	0.000401	0.000401	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000397	0.000397	CcSEcCtD
Salbutamol—Insomnia—Prednisone—systemic scleroderma	0.000394	0.000394	CcSEcCtD
Salbutamol—Paraesthesia—Prednisone—systemic scleroderma	0.000391	0.000391	CcSEcCtD
Salbutamol—Cough—Methotrexate—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Salbutamol—Dyspepsia—Prednisone—systemic scleroderma	0.000383	0.000383	CcSEcCtD
Salbutamol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000382	0.000382	CcSEcCtD
Salbutamol—Chest pain—Methotrexate—systemic scleroderma	0.00038	0.00038	CcSEcCtD
Salbutamol—Myalgia—Methotrexate—systemic scleroderma	0.00038	0.00038	CcSEcCtD
Salbutamol—Arthralgia—Methotrexate—systemic scleroderma	0.00038	0.00038	CcSEcCtD
Salbutamol—Decreased appetite—Prednisone—systemic scleroderma	0.000378	0.000378	CcSEcCtD
Salbutamol—Fatigue—Prednisone—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Salbutamol—Discomfort—Methotrexate—systemic scleroderma	0.000375	0.000375	CcSEcCtD
Salbutamol—Constipation—Prednisone—systemic scleroderma	0.000372	0.000372	CcSEcCtD
Salbutamol—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000364	0.000364	CcSEcCtD
Salbutamol—Infection—Methotrexate—systemic scleroderma	0.000361	0.000361	CcSEcCtD
Salbutamol—Feeling abnormal—Prednisone—systemic scleroderma	0.000359	0.000359	CcSEcCtD
Salbutamol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000357	0.000357	CcSEcCtD
Salbutamol—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000356	0.000356	CcSEcCtD
Salbutamol—Skin disorder—Methotrexate—systemic scleroderma	0.000353	0.000353	CcSEcCtD
Salbutamol—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000352	0.000352	CcSEcCtD
Salbutamol—Anorexia—Methotrexate—systemic scleroderma	0.000347	0.000347	CcSEcCtD
Salbutamol—Urticaria—Prednisone—systemic scleroderma	0.000346	0.000346	CcSEcCtD
Salbutamol—Body temperature increased—Prednisone—systemic scleroderma	0.000344	0.000344	CcSEcCtD
Salbutamol—Abdominal pain—Prednisone—systemic scleroderma	0.000344	0.000344	CcSEcCtD
Salbutamol—Hypotension—Methotrexate—systemic scleroderma	0.00034	0.00034	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000331	0.000331	CcSEcCtD
Salbutamol—Insomnia—Methotrexate—systemic scleroderma	0.000329	0.000329	CcSEcCtD
Salbutamol—Paraesthesia—Methotrexate—systemic scleroderma	0.000327	0.000327	CcSEcCtD
Salbutamol—Dyspnoea—Methotrexate—systemic scleroderma	0.000324	0.000324	CcSEcCtD
Salbutamol—Somnolence—Methotrexate—systemic scleroderma	0.000323	0.000323	CcSEcCtD
Salbutamol—Hypersensitivity—Prednisone—systemic scleroderma	0.000321	0.000321	CcSEcCtD
Salbutamol—Dyspepsia—Methotrexate—systemic scleroderma	0.00032	0.00032	CcSEcCtD
Salbutamol—Decreased appetite—Methotrexate—systemic scleroderma	0.000316	0.000316	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000314	0.000314	CcSEcCtD
Salbutamol—Fatigue—Methotrexate—systemic scleroderma	0.000314	0.000314	CcSEcCtD
Salbutamol—Asthenia—Prednisone—systemic scleroderma	0.000312	0.000312	CcSEcCtD
Salbutamol—Pain—Methotrexate—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Salbutamol—Pruritus—Prednisone—systemic scleroderma	0.000308	0.000308	CcSEcCtD
Salbutamol—Feeling abnormal—Methotrexate—systemic scleroderma	0.0003	0.0003	CcSEcCtD
Salbutamol—Diarrhoea—Prednisone—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Salbutamol—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Salbutamol—Urticaria—Methotrexate—systemic scleroderma	0.000289	0.000289	CcSEcCtD
Salbutamol—Dizziness—Prednisone—systemic scleroderma	0.000288	0.000288	CcSEcCtD
Salbutamol—Abdominal pain—Methotrexate—systemic scleroderma	0.000288	0.000288	CcSEcCtD
Salbutamol—Body temperature increased—Methotrexate—systemic scleroderma	0.000288	0.000288	CcSEcCtD
Salbutamol—Vomiting—Prednisone—systemic scleroderma	0.000277	0.000277	CcSEcCtD
Salbutamol—Rash—Prednisone—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Salbutamol—Dermatitis—Prednisone—systemic scleroderma	0.000274	0.000274	CcSEcCtD
Salbutamol—Headache—Prednisone—systemic scleroderma	0.000273	0.000273	CcSEcCtD
Salbutamol—Hypersensitivity—Methotrexate—systemic scleroderma	0.000268	0.000268	CcSEcCtD
Salbutamol—Asthenia—Methotrexate—systemic scleroderma	0.000261	0.000261	CcSEcCtD
Salbutamol—Nausea—Prednisone—systemic scleroderma	0.000259	0.000259	CcSEcCtD
Salbutamol—Pruritus—Methotrexate—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Salbutamol—Diarrhoea—Methotrexate—systemic scleroderma	0.000249	0.000249	CcSEcCtD
Salbutamol—Dizziness—Methotrexate—systemic scleroderma	0.000241	0.000241	CcSEcCtD
Salbutamol—Vomiting—Methotrexate—systemic scleroderma	0.000231	0.000231	CcSEcCtD
Salbutamol—Rash—Methotrexate—systemic scleroderma	0.000229	0.000229	CcSEcCtD
Salbutamol—Dermatitis—Methotrexate—systemic scleroderma	0.000229	0.000229	CcSEcCtD
Salbutamol—Headache—Methotrexate—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Salbutamol—Nausea—Methotrexate—systemic scleroderma	0.000216	0.000216	CcSEcCtD
